SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Theravance Biopharma Inc. (TBPH) on Tuesday reported second-quarter net income of $54.8 million.
On a per-share basis, the South San Francisco, California-based company said it had profit of $1.08. Losses, adjusted for non-recurring gains, came to 8 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
The biopharmaceutical company posted revenue of $26.2 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $17 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
